Abstract
References
Articles referenced by this article (47)
Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
J Med Chem, (23):9369-9402 2013
MED: 23977883
Title not supplied
MedChemComm 2016
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.
Mol Cell Biol, (12):5447-5454 1992
MED: 1448077
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Proc Natl Acad Sci U S A, (12):5510-5514 1995
MED: 7539918
Purification and characterization of hypoxia-inducible factor 1.
J Biol Chem, (3):1230-1237 1995
MED: 7836384
Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.
Blood, (12):3610-3615 1993
MED: 8260699
Negative regulation of the erythropoietin gene expression by the GATA transcription factors.
Blood, (4):1430-1439 1997
MED: 9028967
HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner.
Blood, (8):3133-3140 2004
MED: 15626745
Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.
J Biol Chem, (36):22642-22647 1997
MED: 9278421
A conserved family of prolyl-4-hydroxylases that modify HIF.
Science, (5545):1337-1340 2001
MED: 11598268
Show 10 more references (10 of 47)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.bmc.2017.05.026
Article citations
Silencing of topical proline hydroxylase domain 2 promotes the healing of rat diabetic wounds by phosphorylating AMPK.
PLoS One, 18(12):e0294566, 01 Dec 2023
Cited by: 0 articles | PMID: 38039326 | PMCID: PMC10691724
Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD).
Front Pharmacol, 14:1202128, 21 Aug 2023
Cited by: 0 articles | PMID: 37670941 | PMCID: PMC10475833
MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior.
Int J Biol Sci, 14(1):100-110, 11 Jan 2018
Cited by: 41 articles | PMID: 29483829 | PMCID: PMC5821053
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light.
J Med Chem, 62(16):7583-7588, 25 Jun 2019
Cited by: 1 article | PMID: 31244107
Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.
Eur J Med Chem, 238:114479, 25 May 2022
Cited by: 1 article | PMID: 35675755
Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia.
Bioorg Med Chem Lett, 108:129799, 15 May 2024
Cited by: 0 articles | PMID: 38754564
Hypoxia-Inducible Factor-Prolyl Hydroxylase Domain Inhibitors to Treat Anemia in Chronic Kidney Disease.
Contrib Nephrol, 198:112-123, 16 Apr 2019
Cited by: 15 articles | PMID: 30991411
Review
Funding
Funders who supported this work.
National Major Science and Technology Project of China (1)
Grant ID: 2014ZX09507002-005-015
National Natural Science Foundation of China (3)
Grant ID: 81302636
Grant ID: 81230078
Grant ID: 81573346